Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matucci

Showing results (281-290 of 295) with videos related to

Pageof 30
Sort By:
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiativeL Gossec, S Paternotte, G J Aanerud, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Arthritis and Rheumatism|June 18, 2010
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian populationJ Wipff, P Dieudé, M Guedj, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
Arthritis and Rheumatism|December 17, 2010
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisP Dieudé, M Guedj, M E Truchetet, et al.
Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiativeL Gossec, S Paternotte, G J Aanerud, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Arthritis and Rheumatism|June 18, 2010
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian populationJ Wipff, P Dieudé, M Guedj, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
Arthritis and Rheumatism|December 17, 2010
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisP Dieudé, M Guedj, M E Truchetet, et al.
Pageof 30